Scientists hunt for clues to personalize sarcoma treatment
NCT ID NCT07432932
Summary
This study aims to understand how personalized chemotherapy given before surgery works for patients with high-risk soft tissue sarcoma. Researchers will collect and analyze tissue samples from 800 patients, comparing those who receive chemotherapy before surgery to those who have surgery alone. The goal is to find biological markers that predict which patients benefit most from this approach.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Royal Marsden Hospital
RECRUITINGLondon, SW3 6JJ, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.